Clinical trial
The Effects of HIV Protease Inhibitors in Severe Sepsis
NCT00346580 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00346580 |
|---|---|
| Title | The Effects of HIV Protease Inhibitors in Severe Sepsis |
| Official title | The Effects of HIV Protease Inhibitors in Severe Sepsis |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | Nelfinavir |
| Enrollment | 60 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Jun 30, 2006 |
| Last update posted | Apr 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: